High TGF-β levels present more aggressive tumor characteristics and may also cause T-cell exhaustion by upregulating PD-1 signaling in HCC, which demonstrates a specific immunosuppressive role of TGF-β in mediating immunotherapy resistance (56–59). Here, TGFB1 is linked to hepatocellular carcinoma.